Antibody Information
General Information of This Antibody
| Antibody ID | ANI0MFAXA |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | Ruzaltatug |
|||||
| Synonyms |
Ruzaltatug
Click to Show/Hide
|
|||||
| Antigen Name | Receptor tyrosine-protein kinase erbB-3 (ERBB3) |
Antigen Info | ||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
SHR-A2009 [Phase 3]
Identified from the Human Clinical Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Related Clinical Trial | |||||
| NCT Number | NCT05394818 | Clinical Status | Phase 1 | ||
| Clinical Description |
An open-label, phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-A2009 for injection in patients with advanced solid tumors.
|
||||
| Experiment 2 Reporting the Activity Date of This ADC | [2] | ||||
| Related Clinical Trial | |||||
| NCT Number | NCT05114759 | Clinical Status | Phase 1 | ||
| Clinical Description |
A phase 1, open-label, multicenter clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-A2009 for injection in patients with advanced solid tumors.
|
||||
References